American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 366-369 , March 2009

Connecting the C's: Coronaries, Creatinine, Compliance, CRUSADE

  • Alan K. Berger, MD

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota
    • Corresponding Author InformationAddress correspondence to Alan K. Berger, MD, University of Minnesota, School of Public Health, Division of Epidemiology and Community Health, 1300 S Second St, Ste 300, Minneapolis, MN 55454
    • ,
  • Charles A. Herzog, MD

      Affiliations

    • Cardiovascular Special Studies Center, United States Renal Data System, University of Minnesota, Minneapolis, Minnesota

References 

  1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2004;110:588–636
  4. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9–17
  5. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42:677–684
  6. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489–495
  7. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  9. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2007;116:e148–e304
  10. Weston CF. Performance indicators in acute myocardial infarction: A proposal for the future assessment of good quality care. Heart. 2008;94:1397–1401
  11. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J. 2002;144:226–232
  12. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan WB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137:555–562
  13. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol. 2003;42:201–208
  14. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563–570
  15. Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89:1003–1008
  16. Patel UD, Ou F-S, Ohman EM, et al. Hospital performance and differences by kidney function in the use of recommended therapies after non–ST-elevation acute coronary syndromes. Am J Kidney Dis. 2009;53:426–437
  17. Beattie JN, Soman SS, Sandberg KR, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 2001;37:1191–1200
  18. Novak JE, Szczech LA. Feast and famine: epidemiology and clinical trials in chronic kidney disease. J Am Soc Nephrol. 2008;19:2–4
  19. Han JH, Chandra A, Mulgund J, et al. Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. Am J Med. 2006;119:248–254
  20. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(1):S1–S266
  21. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA. 2006;296:72–78
  22. Wang OJ, Wang Y, Lichtman JH, Bradley EH, Normand SL, Krumholz HM. “America's Best Hospitals” in the treatment of acute myocardial infarction. Arch Intern Med. 2007;167:1345–1351
  23. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912–1920
  24. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. In: Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases; 2006;p. 178–179
  25. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799–805

PII: S0272-6386(09)00044-4

doi: 10.1053/j.ajkd.2009.01.013

American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 366-369 , March 2009

Article Tools